PURPOSE: 201Tl has been extensively used for myocardial perfusion and viability assessment. Unlike 99mTc-labelled agents, such as 99mTc-sestamibi and 99mTc-tetrofosmine, the regional concentration of 201Tl varies with time. This study is intended to validate a kinetic modelling approach for in vivo quantitative estimation of regional myocardial blood flow (MBF) and volume of distribution of 201Tl using dynamic SPECT. METHODS: Dynamic SPECT was carried out on 20 normal canines after the intravenous administration of 201Tl using a commercial SPECT system. Seven animals were studied at rest, nine during adenosine infusion, and four after beta-blocker administration. Quantitative images were reconstructed with a previously validated technique, employing OS-EM with attenuation-correction, and transmission-dependent convolution subtraction scatter correction. Measured regional time-activity curves in myocardial segments were fitted to two- and three-compartment models. Regional MBF was defined as the influx rate constant (K(1)) with corrections for the partial volume effect, haematocrit and limited first-pass extraction fraction, and was compared with that determined from radio-labelled microspheres experiments. RESULTS: Regional time-activity curves responded well to pharmacological stress. Quantitative MBF values were higher with adenosine and decreased after beta-blocker compared to a resting condition. MBFs obtained with SPECT (MBF(SPECT)) correlated well with the MBF values obtained by the radio-labelled microspheres (MBF(MS)) (MBF(SPECT) = -0.067 + 1.042 x MBF(MS), p < 0.001). The three-compartment model provided better fit than the two-compartment model, but the difference in MBF values between the two methods was small and could be accounted for with a simple linear regression. CONCLUSION: Absolute quantitation of regional MBF, for a wide physiological flow range, appears to be feasible using 201Tl and dynamic SPECT.
PURPOSE: 201Tl has been extensively used for myocardial perfusion and viability assessment. Unlike 99mTc-labelled agents, such as 99mTc-sestamibi and 99mTc-tetrofosmine, the regional concentration of 201Tl varies with time. This study is intended to validate a kinetic modelling approach for in vivo quantitative estimation of regional myocardial blood flow (MBF) and volume of distribution of 201Tl using dynamic SPECT. METHODS: Dynamic SPECT was carried out on 20 normal canines after the intravenous administration of 201Tl using a commercial SPECT system. Seven animals were studied at rest, nine during adenosine infusion, and four after beta-blocker administration. Quantitative images were reconstructed with a previously validated technique, employing OS-EM with attenuation-correction, and transmission-dependent convolution subtraction scatter correction. Measured regional time-activity curves in myocardial segments were fitted to two- and three-compartment models. Regional MBF was defined as the influx rate constant (K(1)) with corrections for the partial volume effect, haematocrit and limited first-pass extraction fraction, and was compared with that determined from radio-labelled microspheres experiments. RESULTS: Regional time-activity curves responded well to pharmacological stress. Quantitative MBF values were higher with adenosine and decreased after beta-blocker compared to a resting condition. MBFs obtained with SPECT (MBF(SPECT)) correlated well with the MBF values obtained by the radio-labelled microspheres (MBF(MS)) (MBF(SPECT) = -0.067 + 1.042 x MBF(MS), p < 0.001). The three-compartment model provided better fit than the two-compartment model, but the difference in MBF values between the two methods was small and could be accounted for with a simple linear regression. CONCLUSION: Absolute quantitation of regional MBF, for a wide physiological flow range, appears to be feasible using 201Tl and dynamic SPECT.
Authors: C H Lau; S Eberl; D Feng; H Iida; P K Lun; W C Siu; Y Tamura; G J Bautovich; Y Ono Journal: IEEE Trans Med Imaging Date: 1998-06 Impact factor: 10.048
Authors: Y Choi; R A Hawkins; S C Huang; R C Brunken; C K Hoh; C Messa; E U Nitzsche; M E Phelps; H R Schelbert Journal: J Nucl Med Date: 1994-05 Impact factor: 10.057
Authors: Y Onishi; Y Yonekura; T Mukai; S Nishizawa; F Tanaka; H Okazawa; K Ishizu; T Fujita; H Shibasaki; J Konishi Journal: J Nucl Med Date: 1995-07 Impact factor: 10.057
Authors: S Takikawa; V Dhawan; P Spetsieris; W Robeson; T Chaly; R Dahl; D Margouleff; D Eidelberg Journal: Radiology Date: 1993-07 Impact factor: 11.105
Authors: Grant T Gullberg; Bryan W Reutter; Arkadiusz Sitek; Jonathan S Maltz; Thomas F Budinger Journal: Phys Med Biol Date: 2010-09-22 Impact factor: 3.609
Authors: M Pissarek; J Meyer-Kirchrath; T Hohlfeld; S Vollmar; A M Oros-Peusquens; U Flögel; C Jacoby; U Krügel; N Schramm Journal: Eur J Nucl Med Mol Imaging Date: 2009-05-07 Impact factor: 9.236
Authors: Moshe Bocher; Ira M Blevis; Leonid Tsukerman; Yigal Shrem; Gil Kovalski; Lana Volokh Journal: Eur J Nucl Med Mol Imaging Date: 2010-06-29 Impact factor: 9.236
Authors: Celeste D Winant; Carina Mari Aparici; Yuval R Zelnik; Bryan W Reutter; Arkadiusz Sitek; Stephen L Bacharach; Grant T Gullberg Journal: Phys Med Biol Date: 2011-12-14 Impact factor: 3.609
Authors: Simona Ben-Haim; Venkatesh L Murthy; Christopher Breault; Rayjanah Allie; Arkadiusz Sitek; Nathaniel Roth; Jolene Fantony; Stephen C Moore; Mi-Ae Park; Marie Kijewski; Athar Haroon; Piotr Slomka; Kjell Erlandsson; Rafael Baavour; Yoel Zilberstien; Jamshed Bomanji; Marcelo F Di Carli Journal: J Nucl Med Date: 2013-04-11 Impact factor: 10.057